Neoadjuvant immunotherapy driven bladder preservation for muscle invasive bladder cancer
Saved in:
| Main Authors: | Jiao Hu, Luzhe Yan, Jinhui Liu, Minfeng Chen, Yunbo He, Benyi Fan, Bo Peng, Long Wang, Weibin Hou, Chao Li, Bosen You, Meng Zhang, Wenze Li, Jiaxing Wang, Hongzhou Cai, Shenglin Gao, Yang Liu, Dingshan Deng, Huihuang Li, Guanghui Gong, Jiansheng Tang, Chengyong Wang, Xiaofeng Yang, Liang Wei, Guangzheng Lin, Ruizhe Wang, Xiao Guan, Shiyu Tong, Yangle Li, Wei He, Zhiyong Cai, Peihua Liu, Yu Gan, Yu Cui, Yuanqing Dai, Yi Cai, Zefu Liu, Jiatong Xiao, Zhenyu Nie, Zhenyu Ou, Jinbo Chen, Xi Guo, Xiongbing Zu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | iMeta |
| Online Access: | https://doi.org/10.1002/imt2.70063 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48‐ADC) combined immunotherapy in patients with muscle‐invasive bladder cancer: A multi‐center real‐world study
by: Jiao Hu, et al.
Published: (2025-06-01) -
Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48
by: Xin Gao, et al.
Published: (2025-08-01) -
Enhancing the therapeutic efficacy of gemcitabine in bladder cancer through TGF-β1 inhibition and pluronic F-127-based microsphere delivery
by: Yaoyao Xiong, et al.
Published: (2025-07-01) -
Endocrine disruptors and bladder function: the role of phthalates in overactive bladder
by: Li Liu, et al.
Published: (2024-12-01) -
Artificial intelligence application in the diagnosis and treatment of bladder cancer: advance, challenges, and opportunities
by: Xiaoyu Ma, et al.
Published: (2024-11-01)